Cited by 24Cardiac electrophysiology and arrhythmiasCardiac Fibrosis and RemodelingTissue Engineering and Regenerative Medicine

Fibroblasts slow conduction velocity in a reconstituted tissue model of fibrotic cardiomyopathy

Open access
Spencer, Teresa M., Blumenstein, Ryan F., Pryse, Kenneth M., Lee, Sheng-Lin, Glaubke, David A., Carlson, Brian E., Elson, Elliot L., Genin, Guy M.·2017·ACS Biomaterials Science & Engineering

Abstract

Myocardial function deteriorates over the course of fibrotic cardiomyopathy, because of electrophysiological and mechanical effects of myofibroblasts that are not completely understood. Although a range of experimental model systems and associated theoretical treatments exist at the levels of isolated cardiomyocytes and planar cocultures of myofibroblasts and cardiomyocytes, interactions between these cell types at the tissue level are less clear. We studied these interactions through an engineered heart tissue (EHT) model of fibrotic myocardium and a mathematical model of the effects of cellular composition on EHT impulse conduction velocity. The EHT model allowed for modulation of cardiomyocyte and myofibroblast volume fractions, and observation of cell behavior in a three-dimensional environment that is more similar to native heart tissue than is planar cell culture. The cardiomyocyte and myofibroblast volume fractions determined the retardation of impulse conduction (spread of the action potential) in EHTs as measured by changes of the fluorescence of the Ca 2+ probe, Fluo-2. Interpretation through our model showed retardation far in excess of predictions by homogenization theory, with conduction ceasing far below the fibroblast volume fraction associated with steric percolation. Results point to an important multiscale structural role of myofibroblasts in attenuating impulse conduction in fibrotic cardiomyopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsbiomaterials.6b00576

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [18]Genin GM; Abney TM; Wakatsuki T; Elson EL Mechanobiology of Cell-Cell and Cell-Matrix Interactions; Springer, 2011; pp 75– 103.
  2. [19]Asnes CF; Marquez JP; Elson EL; Wakatsuki T Reconstitution of the frankstarling mechanism in engineered heart tissues. Biophysical Journal 2006, 91, 1800– 1810. 16782784 PMC1544304

Cited by

Sorted by citations

Authors
Spencer, T. M., Blumenstein, R. F., Pryse, K. M., Lee, S.-L., Glaubke, D. A., Carlson, B. E., Elson, E. L., & Genin, G. M.
Affiliations
  • Washington University in St. Louis (US)
  • University of Michigan (US)
Corresponding author
Genin, Guy M.
Venue
ACS Biomaterials Science & Engineering
Published
2016-10-31
Volume
3
Issue
11
Pages
3022-3028
ISSN
2373-9878 (ISSN-L)
OpenAlex
W2532467450
Cited by
23
References
52
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 2
FWCI
1.65
Type
journal article
Language
en
Open access
Locations
  • ACS Biomaterials Science & Engineering (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Science Foundation (DGE-1143954)
  • U.S. Department of Health and Human Services (R01HL109505)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
myofibroblasts, fibroblasts, engineered heart tissue, action potential propagation, volume fraction, homogenization theory, multiscale modeling, calcium imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review